Profound Medical Corp.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Profound Medical Corp. - overview
Established
2008
Location
Mississauga, ON, Canada
Primary Industry
Medical Devices & Equipment
About
Profound Medical Corp. , based in Canada, specializes in developing innovative ultrasound ablation technologies to provide incision-free treatment for prostate conditions, enhancing patient care through advanced medical devices. Founded in 2008 in Mississauga, Canada, Profound Medical Corp. focuses on developing advanced technologies for treating prostate cancer and benign prostatic hyperplasia (BPH).
The company's founders include Boudino de Jong, Joseph DeJonge, and Rajiv Chopra, with Arun Menawat serving as the CEO. The company has successfully raised USD 35. 00 mn in PIPE funding on December 5, 2024, which marks the total amount raised to date. Profound Medical has completed a total of 9 deals throughout its history.
Profound Medical specializes in innovative, incision-free ultrasound ablation technologies, primarily focusing on the TULSA-PRO® system. This advanced medical device uses transurethral ultrasound ablation to treat localized prostate cancer and benign prostatic hyperplasia (BPH), utilizing real-time MRI imaging for precise treatment delivery. The TULSA Procedure offers customizable treatment plans, allowing physicians to effectively target specific tissue volumes. The product has received CE marking, Health Canada approval, and FDA 510(k) clearance, enabling its use across various international markets, including Europe, Canada, and the United States.
Profound Medical's clientele includes hospitals and specialized medical centers, with end-users being healthcare professionals administering the TULSA Procedure to patients seeking treatment for prostate conditions. In 2022, Profound Medical generated revenue of USD 6. 68 mn, while reporting an EBITDA of USD -30. 52 mn for the same year.
The company generates revenue through the sale of its proprietary TULSA-PRO® system and associated services, which include training and support for healthcare providers utilizing the technology. Revenue is typically derived from direct sales to medical institutions, partnerships for product implementation, and ongoing customer support agreements following the initial sale of the TULSA-PRO® system. In December 2024, Profound Medical Corp. raised USD 35 mn in PIPE funding led by new investors Lake Street Capital and Raymond James Ltd.
This funding will support the commercialization and development of the TULSA-PRO® and Sonalleve® systems in the U. S. and globally, as well as for working capital and general corporate purposes. The company aims to enhance its product offerings and expand into new markets, with a focus on increasing its presence in the U.
S. healthcare market.
Current Investors
BDC Capital, Genesys Capital Management, MaRS Investment Accelerator Fund
Primary Industry
Medical Devices & Equipment
Sub Industries
Oncology/Cancer Treatment, Medical Devices & Equipment
Website
www.profoundmedical.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Profound Medical Corp. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Placement/Follow on | Completed | Profound Medical Corp. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.